Novo Holdings A/S’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Novo Holdings A/S’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-151,816	Closed	-$7.12M	–	36
2020 Q1	$7.12M	Buy	151,816 +121,468	+400%	+$7.78M	0.48%	17
2019 Q4	$2.21M	Hold	30,348	–	–	0.14%	27
2019 Q3	$1.58M	Buy	+30,348	New	+$1.61M	0.27%	26

Other funds holding MYOK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Novo Holdings A/S's MYOK Position: Q2 2020 in Review

Novo Holdings A/S sold out of MyoKardia, Inc. Common Stock (MYOK) in Q2 2020, closing a stake of 151,816 shares — an estimated $7.12M sold.

Novo Holdings A/S first reported a position in MYOK in Q3 2019 and held it in 3 quarters. The position peaked at $7.12M in Q1 2020. 235 funds tracked by Wall St. Rank hold MYOK as of Q2 2020.

Novo Holdings A/S reported no remaining MyoKardia, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
Novo Holdings A/S sold 151,816 MyoKardia, Inc. Common Stock shares in Q2 2020, an estimated $7.12M.
Novo Holdings A/S first reported a position in MyoKardia, Inc. Common Stock in Q3 2019 and held it in 3 quarters.
Novo Holdings A/S's MyoKardia, Inc. Common Stock position peaked at $7.12M in Q1 2020.
235 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q2 2020.

Based on Novo Holdings A/S's 13F filing for Q2 2020, filed 14 Aug 2020.